FF Principal Investigator/Program Director (Last, first, middia):

BIOGRAPHICAL SKETCH
Give the following information for the kay personnel and consultants and collaborators. Begin with the principal
investigator/program director. Photocopy this page for each person.

NAME POSHIONGUHAte Chief of Staff for Res.& Dev,
Glenn R. Cunningham, M.D. VA Medical Center and Chief, Div. Endo &

 

Metabolism, Baylor College of Medicine

    
     

  

University of Oklahoma Liberal Arts

University of Oklahoma Medicine

Duke University Medical Center Medicine
Fellowship

Duke University Medical Center

ke University Med ente e p
RESEARCH AND PROFESSIONAL EXPERIENCE: Concluding with present position, list, in chronological order, previous employment, experience, and
honors. Key personnel include the principal investigator and any other individuals who participate in the scientific development or execution of the project.
Key personne! typicalty will Include ali Individuais with doctoral or other professional degrees, but in some projects will inciude individuals at tha masters or
baccalaureate level provided they contribute in a substantive way to the scientific development or execution of the project. Include present membership on
any Federal Govemment public advisory committee. List, in chronological order, the titles, ail authors, and complete references to ali publications during the
past three years and to representative eartier publications pertinent to this application. If the list of publications in the last three years exceeds two pages,

. T TWO PAG
solar iy ap.getnert PRR. edical Corps. Brooke General Hospital;

Chief, Endocrinology Service, San Antonio, Texas
1973-89 Chief, Endocrinology Section, VA Medical Center, Houston, Texas
1973-79 Assist. Professor of Medicine, Baylor College of Medicine
1975-94 Assistant Professor of Cell Biology, Baylor College of Medicine
1979-91 Associate Professor of Medicine, Baylor College of Medicine
1980-86 Director, Endocrine Laboratory, The Methodist Hospital,
1981-84 Director, Core Hormone Radioimmunoassay Laboratory;

Diabetes and Endocrinology Research Center, Baylor College of Medicine
1990-92 ~ Director, Core Hormone Radioimmunoassay Laboratory.

Diabetes and Endocrinology Research Center, Baylor College of Med.
1986-88 Assistant Chief, Medical Service, VA Medical Center,
1988-89 Acting Chief, Medical Service, VA Medical Center
1988-89 Acting ACOS, Research Service, VA Medical Center

 
 

     

  
 
 

ei

   

1989- Associate Chief of Staff. Research Service, VA Medical Center

1990-92 Acting Chief, Division of Endocrinol and Metab, Baylor College Medicine
1991- Professor of Medicine, Baylor College of Medicine, Houston, Texas

1992- Chief, Division of Endocrino! and Metab, Baylor College of Med.

1994- Professor of Cell Biology, Baylor College of Medicine

Societies and Honors: Alpha Omega Alpha, American Federation for
Clinical Research, Southern Society for Clinical Investigation, The Endocrine Society,
American Society of Andrology, American Diabetes Association; Past President -
American Society of Andrology; Editorial Board - Journal of Clinical Endocrinology and

Metabolism; Associate Editor, Journal of Andrology
Five Pertinent Publications

Ghusn H, Shao TC, Klima M, Cunningham GR: 4-MAPC, a 5a-reductase inhibitor,
reduces rat ventral prostate weight. DNA and prostatein concentrations. J Andrology;
12:315-322, 1991.

Shao TC, Kong A, Marafelia P, Cunningham GR: Effects of finasteride on the rat
ventral prostate. J Andrology 14:79-86, 1993.

Shao TC, Kong A, Cunningham GR: Effects of 4~-MAPC, a 5a-reductase inhibitor,
and cyproterone acetate on regrowth of the rat ventral prostate. The Prostate
24:212-220, 1994. ;

Shao TC, Marcelli M, Kong A, Cunningham GR: Anti-androgen effects of the
aromatase inhibitor, atamestane. J Andrology 16:100-107, 1995.

Cunningham GR, Hirshkowitz M: The effect of a 5a-reductase inhibitor on sleep-
related erections, potency and libido in health male volunteers. J Clin Endocrinol

PHS 398 (Rev. 9/91) {Form Page 6) Page FF

Number pages consecutively at the bottom throughout the application. Do not use suffixes such as 3a, 36.

 

to ee ce ne eS Seen em em Sree eae pe